Inventor
Francois Romagne
Inventor
La Ciotat, FR
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
A61KPreparations for medical, dental or toiletry purposes20%
G01NInvestigating or analysing materials by determining their chemical or physical properties10%
C12NMicroorganisms or enzymes8%
C07CAcyclic or carbocyclic compounds3%
C07DHeterocyclic compounds3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture3%
B82YSpecific uses or applications of nanostructures1%
PatentTitleYear
10,675,359Enzymatic conjugation of antibodies202010,434,180Enzymatic conjugation of polypeptides201910,253,095Anti-KIR combination treatments and methods201910,160,810Monoclonal antibodies against NKG2A201810,132,799Screening of conjugated antibodies201810,059,765Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds201810,036,010Recognition tags for TGase-mediated conjugation20189,764,038'Enzymatic conjugation of antibodies'20179,717,803'Enzymatic conjugation of polypeptides'20179,447,185'Compositions and methods for treating proliferative disorders'20169,427,478'Enzymatic conjugation of polypeptides'20169,333,255'Methods of enhancing antibody-based antiviral therapies by administering KIR2DL-binding antibodies'20169,090,876'Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds'20159,067,997'Anti-KIR antibodies for the treatment of inflammatory and autoimmune disorders'20158,993,319'Monoclonal antibodies against NKG2A'20158,981,065'Human anti-KIR antibodies'20158,614,307'Nucleic acids encoding human anti-kir antibodies'20138,551,483'Methods of treating viral infections by administering KIR2DL-binding antibodies'20138,119,775'Human anti-KIR antibodies'20127,803,376'Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2018Patents assigned to INNATE PHARMA SA (7)· patent assignee history
2010–2018Based in La Ciotat, FR· patent location history
2012–2019Patents assigned to ROMAGNE FRANCOIS (8)· patent assignee history
2012–2019Patents assigned to INNATE PHARMA SAS (6)· patent assignee history
2015–2020Based in Marseilles, FR· patent location history
2016–2020Patents assigned to INNATE PHARMA (7)· patent assignee history
2016–2020Patents assigned to SCHERRER INST PAUL (7)· patent assignee history
2019Based in Marseille, FR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ROMAGNE FRANCOISself | 8 | 2012–2019 |
| INNATE PHARMA | 7 | 2016–2020 |
| INNATE PHARMA SA | 7 | 2010–2018 |
| SCHERRER INST PAUL | 7 | 2016–2020 |
| INNATE PHARMA SAS | 6 | 2012–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| La Ciotat, FR | 10 | 2010–2018 |
| Marseilles, FR | 9 | 2015–2020 |
| Marseille, FR | 1 | 2019 |